People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Other Health Care, Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cleveland HeartLab, Inc. | — | Other Health Care | Series B | $35.8M | $61.0M | 2011 |
| Cancer Genetics, Inc | — | Biotechnology | Series A | $33.1M | $272.0M | 2010 |
| Spectrascience Inc | — | Other Health Care | Seed | $7.9M | $31.0M | 2009 |
| Socrates Health Solutions, Inc. | — | Healthtech | Seed | $3.7M | $55.5M | 2015 |
| US Biologic, Inc. | — | Biotechnology | Pre-Seed | $1.0M | $55.2M | 2017 |
Tommy Thompson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tommy Thompson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Pappajohn | 2 | 10 |
| David Williams | 1 | 17 |
| Scott Smith | 1 | 16 |
| Tommy G. Thompson | 1 | 7 |
| Caleb Winder | 1 | 5 |
| Michael Gorton | 1 | 5 |
| Mark McWilliams | 1 | 4 |
| Keith Kerman | 1 | 4 |
| Andrew Pecora | 1 | 4 |
| Franklyn G. Prendergast | 1 | 3 |
| Edward J. Sitar | 1 | 3 |
| Les Vinney | 1 | 2 |
| Thomas Monath | 1 | 2 |
| Riccardo Dalla-Favera | 1 | 2 |
| Panna Sharma | 1 | 2 |
| Gus Lawlor | 1 | 2 |
| Steve Gullans | 1 | 2 |
| Steven Landau | 1 | 2 |
| Rebecca G. Holland | 1 | 1 |
| Mark P. McWilliams | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.